ATE280830T1 - HEMMUNG VON MENSCHLICHEM PAPILLOMAVIRUS DURCH ßHAIRPIN-RIBOZYMEß - Google Patents

HEMMUNG VON MENSCHLICHEM PAPILLOMAVIRUS DURCH ßHAIRPIN-RIBOZYMEß

Info

Publication number
ATE280830T1
ATE280830T1 AT95920437T AT95920437T ATE280830T1 AT E280830 T1 ATE280830 T1 AT E280830T1 AT 95920437 T AT95920437 T AT 95920437T AT 95920437 T AT95920437 T AT 95920437T AT E280830 T1 ATE280830 T1 AT E280830T1
Authority
AT
Austria
Prior art keywords
ribozymes
ßhairpin
inhibition
hpv
human papillomavirus
Prior art date
Application number
AT95920437T
Other languages
English (en)
Inventor
Arnold Hampel
Joseph Dipaolo
Andrew Siwkowski
Original Assignee
Us Gov Health & Human Serv
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Univ Illinois filed Critical Us Gov Health & Human Serv
Priority claimed from PCT/US1995/006016 external-priority patent/WO1995031552A2/en
Application granted granted Critical
Publication of ATE280830T1 publication Critical patent/ATE280830T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/122—Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95920437T 1994-05-13 1995-05-15 HEMMUNG VON MENSCHLICHEM PAPILLOMAVIRUS DURCH ßHAIRPIN-RIBOZYMEß ATE280830T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24266594A 1994-05-13 1994-05-13
PCT/US1995/006016 WO1995031552A2 (en) 1994-05-13 1995-05-15 Human papilloma virus inhibition by a hairpin ribozyme

Publications (1)

Publication Number Publication Date
ATE280830T1 true ATE280830T1 (de) 2004-11-15

Family

ID=22915710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95920437T ATE280830T1 (de) 1994-05-13 1995-05-15 HEMMUNG VON MENSCHLICHEM PAPILLOMAVIRUS DURCH ßHAIRPIN-RIBOZYMEß

Country Status (6)

Country Link
EP (2) EP1327683A3 (de)
JP (2) JPH10500307A (de)
AT (1) ATE280830T1 (de)
AU (1) AU712160B2 (de)
CA (1) CA2190102A1 (de)
DE (1) DE69533694T2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2135646A1 (en) * 1992-05-11 1993-11-25 Kenneth G. Draper Method and reagent for inhibiting viral replication

Also Published As

Publication number Publication date
EP1327683A3 (de) 2004-01-07
EP0759992B1 (de) 2004-10-27
CA2190102A1 (en) 1995-11-23
DE69533694D1 (de) 2004-12-02
JPH10500307A (ja) 1998-01-13
JP2006149387A (ja) 2006-06-15
DE69533694T2 (de) 2006-02-16
EP0759992A1 (de) 1997-03-05
EP1327683A2 (de) 2003-07-16
AU712160B2 (en) 1999-10-28
AU2588795A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
WO1995031552A3 (en) Human papilloma virus inhibition by a hairpin ribozyme
NO20000850D0 (no) Vaksine
WO1999029890A3 (en) Assessment of human papilloma virus-related disease
LU91390I2 (fr) "La combinaison de particules viroïdes de la protéine L1 recombinante du papillomavirus humain de types 16 et 18" - CERVARIX
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
LU91391I2 (fr) "La combinaison de particules viroïdes de la protéine L1 recombinante du papillomavirus humain de types 16 et 18" Cervarix
CA2420089A1 (en) Diagnosis method of fibrotic disease using biochemical markers
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
ECSP045300A (es) Antígenos virales
DK1021722T3 (da) Forbedringer i eller relateret til screening for papillomavira
ATE369428T1 (de) Behandlung von gebärmutterhalskrebs
MC2212A1 (fr) Procede de fabrication d'une construction artificielle de grande-dimension au fond d'une piece d'eau,comme par exemple une ile artificielle,appareil pour executer le procede selon l'invention et forme de realisation preferee de sa construction
KR910019641A (ko) 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프
EA200701633A1 (ru) Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
NZ305188A (en) DNA encoding Human Papilloma Virus (hPV)type 18
ATE280830T1 (de) HEMMUNG VON MENSCHLICHEM PAPILLOMAVIRUS DURCH ßHAIRPIN-RIBOZYMEß
DK0591376T3 (da) DNA-sekvenser af papilloma-virus af typen HPV42 samt anvendelse heraf til diagnose
BR0111393A (pt) Métodos de tratamento de doenças virais com il-18 e suas combinações
ATE264925T1 (de) Oligonukleotidstartermoleküle zur effizienten multiplexdetektion vom hepatitis c virus (hcv) und vom humanen immundefizienzvirus (hiv) und methoden zu ihrer verwendung
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
DK0750669T3 (da) Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra
FI98467B (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
ATE258222T1 (de) Synthetische hpv11 virusartige partikel
MX9605514A (es) Inhibicion de virus de papiloma humano mediante una ribozima de horquilla.
DE69727830T2 (de) Synthetische hpv-16 virusähnliche partikel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties